PP1RA_HUMAN - dbPTM
PP1RA_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID PP1RA_HUMAN
UniProt AC Q96QC0
Protein Name Serine/threonine-protein phosphatase 1 regulatory subunit 10
Gene Name PPP1R10
Organism Homo sapiens (Human).
Sequence Length 940
Subcellular Localization Nucleus . Found in discrete nucleoplasmic bodies and within nucleoli. Associates with chromatin during interphase, excluded from condensed chromosomes during early mitosis and is reloaded onto chromosomes at the late telophase (By similarity)..
Protein Description Scaffold protein which mediates the formation of the PTW/PP1 phosphatase complex by providing a binding platform to each component of the complex. The PTW/PP1 phosphatase complex plays a role in the control of chromatin structure and cell cycle progression during the transition from mitosis into interphase. Mediates interaction of WDR82 and PPP1CA. Inhibitor of PPP1CA and PPP1CC phosphatase activities. Has inhibitory activity on PPP1CA only when phosphorylated. Binds to mRNA, single-stranded DNA (ssDNA), poly(A) and poly(G) homopolymers (By similarity)..
Protein Sequence MGSGPIDPKELLKGLDSFLNRDGEVKSVDGISKIFSLMKEARKMVSRCTYLNILLQTRSPEILVKFIDVGGYKLLNNWLTYSKTTNNIPLLQQILLTLQHLPLTVDHLKQNNTAKLVKQLSKSSEDEELRKLASVLVSDWMAVIRSQSSTQPAEKDKKKRKDEGKSRTTLPERPLTEVKAETRAEEAPEKKREKPKSLRTTAPSHAKFRSTGLELETPSLVPVKKNASTVVVSDKYNLKPIPLKRQSNVAAPGDATPPAEKKYKPLNTTPNATKEIKVKIIPPQPMEGLGFLDALNSAPVPGIKIKKKKKVLSPTAAKPSPFEGKTSTEPSTAKPSSPEPAPPSEAMDADRPGTPVPPVEVPELMDTASLEPGALDAKPVESPGDPNQLTRKGRKRKSVTWPEEGKLREYFYFELDETERVNVNKIKDFGEAAKREILSDRHAFETARRLSHDNMEEKVPWVCPRPLVLPSPLVTPGSNSQERYIQAEREKGILQELFLNKESPHEPDPEPYEPIPPKLIPLDEECSMDETPYVETLEPGGSGGSPDGAGGSKLPPVLANLMGSMGAGKGPQGPGGGGINVQEILTSIMGSPNSHPSEELLKQPDYSDKIKQMLVPHGLLGPGPIANGFPPGGPGGPKGMQHFPPGPGGPMPGPHGGPGGPVGPRLLGPPPPPRGGDPFWDGPGDPMRGGPMRGGPGPGPGPYHRGRGGRGGNEPPPPPPPFRGARGGRSGGGPPNGRGGPGGGMVGGGGHRPHEGPGGGMGNSSGHRPHEGPGGGMGSGHRPHEGPGGSMGGGGGHRPHEGPGGGISGGSGHRPHEGPGGGMGAGGGHRPHEGPGGSMGGSGGHRPHEGPGHGGPHGHRPHDVPGHRGHDHRGPPPHEHRGHDGPGHGGGGHRGHDGGHSHGGDMSNRPVCRHFMMKGNCRYENNCAFYHPGVNGPPLP
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
3Phosphorylation-----MGSGPIDPKE
-----CCCCCCCHHH
39.8530631047
13UbiquitinationIDPKELLKGLDSFLN
CCHHHHHHHHHHHHC
70.7921890473
26AcetylationLNRDGEVKSVDGISK
HCCCCCCCCHHHHHH
40.2226051181
27PhosphorylationNRDGEVKSVDGISKI
CCCCCCCCHHHHHHH
30.5321406692
32PhosphorylationVKSVDGISKIFSLMK
CCCHHHHHHHHHHHH
25.8120068231
33AcetylationKSVDGISKIFSLMKE
CCHHHHHHHHHHHHH
45.9426051181
33UbiquitinationKSVDGISKIFSLMKE
CCHHHHHHHHHHHHH
45.9421890473
36PhosphorylationDGISKIFSLMKEARK
HHHHHHHHHHHHHHH
30.9020068231
39AcetylationSKIFSLMKEARKMVS
HHHHHHHHHHHHHHH
54.2225953088
49PhosphorylationRKMVSRCTYLNILLQ
HHHHHHHHHHHHHHH
29.9022210691
57PhosphorylationYLNILLQTRSPEILV
HHHHHHHCCCHHHEE
32.8422210691
115AcetylationLKQNNTAKLVKQLSK
HHHCCHHHHHHHHHC
52.3425953088
118AcetylationNNTAKLVKQLSKSSE
CCHHHHHHHHHCCCC
56.8327452117
118UbiquitinationNNTAKLVKQLSKSSE
CCHHHHHHHHHCCCC
56.83-
121PhosphorylationAKLVKQLSKSSEDEE
HHHHHHHHCCCCHHH
28.1830624053
134PhosphorylationEELRKLASVLVSDWM
HHHHHHHHHHHHHHH
26.81-
138PhosphorylationKLASVLVSDWMAVIR
HHHHHHHHHHHHHHH
22.76-
149PhosphorylationAVIRSQSSTQPAEKD
HHHHHCCCCCCCCHH
24.35-
150PhosphorylationVIRSQSSTQPAEKDK
HHHHCCCCCCCCHHH
43.76-
168PhosphorylationKDEGKSRTTLPERPL
HCCCCCCCCCCCCCC
39.5128555341
179SumoylationERPLTEVKAETRAEE
CCCCCHHHHHHHHHH
33.98-
179SumoylationERPLTEVKAETRAEE
CCCCCHHHHHHHHHH
33.9817000644
200PhosphorylationEKPKSLRTTAPSHAK
CCCCCCCCCCCCCHH
32.3830576142
207AcetylationTTAPSHAKFRSTGLE
CCCCCCHHHHCCCCE
35.5719608861
207UbiquitinationTTAPSHAKFRSTGLE
CCCCCCHHHHCCCCE
35.5719608861
211PhosphorylationSHAKFRSTGLELETP
CCHHHHCCCCEEECC
41.3428555341
217PhosphorylationSTGLELETPSLVPVK
CCCCEEECCCEEECC
30.7028555341
224AcetylationTPSLVPVKKNASTVV
CCCEEECCCCCCEEE
33.9525953088
236PhosphorylationTVVVSDKYNLKPIPL
EEEEECCCCCEECCC
30.62-
239AcetylationVSDKYNLKPIPLKRQ
EECCCCCEECCCCCC
36.9423236377
239UbiquitinationVSDKYNLKPIPLKRQ
EECCCCCEECCCCCC
36.9421890473
244AcetylationNLKPIPLKRQSNVAA
CCEECCCCCCCCCCC
42.9325953088
244MethylationNLKPIPLKRQSNVAA
CCEECCCCCCCCCCC
42.9369475
247PhosphorylationPIPLKRQSNVAAPGD
ECCCCCCCCCCCCCC
36.9930266825
256PhosphorylationVAAPGDATPPAEKKY
CCCCCCCCCCHHHCC
34.2530266825
261AcetylationDATPPAEKKYKPLNT
CCCCCHHHCCCCCCC
64.6123749302
262AcetylationATPPAEKKYKPLNTT
CCCCHHHCCCCCCCC
50.4330583163
262SumoylationATPPAEKKYKPLNTT
CCCCHHHCCCCCCCC
50.4328112733
263PhosphorylationTPPAEKKYKPLNTTP
CCCHHHCCCCCCCCC
28.9829396449
264AcetylationPPAEKKYKPLNTTPN
CCHHHCCCCCCCCCC
52.4926051181
268PhosphorylationKKYKPLNTTPNATKE
HCCCCCCCCCCCCCE
51.8421712546
269PhosphorylationKYKPLNTTPNATKEI
CCCCCCCCCCCCCEE
17.3025159151
273PhosphorylationLNTTPNATKEIKVKI
CCCCCCCCCEEEEEE
35.5322199227
274AcetylationNTTPNATKEIKVKII
CCCCCCCCEEEEEEC
55.8423749302
274UbiquitinationNTTPNATKEIKVKII
CCCCCCCCEEEEEEC
55.8419608861
297PhosphorylationGFLDALNSAPVPGIK
CHHHHHHCCCCCCCE
34.5020068231
313PhosphorylationKKKKKVLSPTAAKPS
CCCCEECCCCCCCCC
24.1629255136
315PhosphorylationKKKVLSPTAAKPSPF
CCEECCCCCCCCCCC
35.5522167270
318AcetylationVLSPTAAKPSPFEGK
ECCCCCCCCCCCCCC
43.4926051181
320PhosphorylationSPTAAKPSPFEGKTS
CCCCCCCCCCCCCCC
41.3323927012
326PhosphorylationPSPFEGKTSTEPSTA
CCCCCCCCCCCCCCC
52.3026074081
327PhosphorylationSPFEGKTSTEPSTAK
CCCCCCCCCCCCCCC
33.9726074081
328PhosphorylationPFEGKTSTEPSTAKP
CCCCCCCCCCCCCCC
58.0926074081
331PhosphorylationGKTSTEPSTAKPSSP
CCCCCCCCCCCCCCC
34.4626074081
332PhosphorylationKTSTEPSTAKPSSPE
CCCCCCCCCCCCCCC
49.7926074081
336PhosphorylationEPSTAKPSSPEPAPP
CCCCCCCCCCCCCCC
58.7928387310
337PhosphorylationPSTAKPSSPEPAPPS
CCCCCCCCCCCCCCH
41.6428387310
344PhosphorylationSPEPAPPSEAMDADR
CCCCCCCHHHCCCCC
36.6126074081
354PhosphorylationMDADRPGTPVPPVEV
CCCCCCCCCCCCCCC
24.6426074081
367PhosphorylationEVPELMDTASLEPGA
CCCCCCCCCCCCCCC
12.2726074081
369PhosphorylationPELMDTASLEPGALD
CCCCCCCCCCCCCCC
35.0426074081
382PhosphorylationLDAKPVESPGDPNQL
CCCCCCCCCCCHHHC
34.1219664994
390PhosphorylationPGDPNQLTRKGRKRK
CCCHHHCCCCCCCCC
22.1426552605
398PhosphorylationRKGRKRKSVTWPEEG
CCCCCCCCCCCCCCC
28.8925159151
400PhosphorylationGRKRKSVTWPEEGKL
CCCCCCCCCCCCCCE
42.2519691289
406AcetylationVTWPEEGKLREYFYF
CCCCCCCCEEEEEEE
47.8825953088
4252-HydroxyisobutyrylationTERVNVNKIKDFGEA
CCCCCHHHHHHHHHH
47.02-
441MethylationKREILSDRHAFETAR
HHHHHCCHHHHHHHH
21.47115488023
451PhosphorylationFETARRLSHDNMEEK
HHHHHHHCCCCHHHC
27.3024247654
471PhosphorylationPRPLVLPSPLVTPGS
CCCEECCCCCCCCCC
27.0629255136
475PhosphorylationVLPSPLVTPGSNSQE
ECCCCCCCCCCCHHH
29.6123312004
491UbiquitinationYIQAEREKGILQELF
HHHHHHHHCHHHHHH
58.43-
501UbiquitinationLQELFLNKESPHEPD
HHHHHCCCCCCCCCC
62.81-
503PhosphorylationELFLNKESPHEPDPE
HHHCCCCCCCCCCCC
32.9224719451
527PhosphorylationIPLDEECSMDETPYV
CCCCCCCCCCCCCCE
32.3320873877
531PhosphorylationEECSMDETPYVETLE
CCCCCCCCCCEEECC
18.6920873877
533PhosphorylationCSMDETPYVETLEPG
CCCCCCCCEEECCCC
20.5220873877
536PhosphorylationDETPYVETLEPGGSG
CCCCCEEECCCCCCC
26.7830576142
542PhosphorylationETLEPGGSGGSPDGA
EECCCCCCCCCCCCC
45.9930278072
545PhosphorylationEPGGSGGSPDGAGGS
CCCCCCCCCCCCCCC
24.2830278072
552PhosphorylationSPDGAGGSKLPPVLA
CCCCCCCCCCCHHHH
30.0630278072
586PhosphorylationINVQEILTSIMGSPN
CCHHHHHHHHHCCCC
23.1317081983
587PhosphorylationNVQEILTSIMGSPNS
CHHHHHHHHHCCCCC
13.7225159151
591PhosphorylationILTSIMGSPNSHPSE
HHHHHHCCCCCCCCH
11.9725159151
594PhosphorylationSIMGSPNSHPSEELL
HHHCCCCCCCCHHHH
39.9121712546
597PhosphorylationGSPNSHPSEELLKQP
CCCCCCCCHHHHHCC
37.9824300666
602UbiquitinationHPSEELLKQPDYSDK
CCCHHHHHCCCCHHH
72.85-
606PhosphorylationELLKQPDYSDKIKQM
HHHHCCCCHHHHHHH
26.0026074081
607PhosphorylationLLKQPDYSDKIKQML
HHHCCCCHHHHHHHH
39.5526074081
609UbiquitinationKQPDYSDKIKQMLVP
HCCCCHHHHHHHHCC
45.95-
665DimethylationPGGPVGPRLLGPPPP
CCCCCCHHHCCCCCC
36.29-
665MethylationPGGPVGPRLLGPPPP
CCCCCCHHHCCCCCC
36.2924129315
674DimethylationLGPPPPPRGGDPFWD
CCCCCCCCCCCCCCC
68.45-
674MethylationLGPPPPPRGGDPFWD
CCCCCCCCCCCCCCC
68.4530762913
688MethylationDGPGDPMRGGPMRGG
CCCCCCCCCCCCCCC
52.9154558187
693MethylationPMRGGPMRGGPGPGP
CCCCCCCCCCCCCCC
50.4824129315
705MethylationPGPGPYHRGRGGRGG
CCCCCCCCCCCCCCC
30.5724411411
707MethylationPGPYHRGRGGRGGNE
CCCCCCCCCCCCCCC
44.3354558195
710MethylationYHRGRGGRGGNEPPP
CCCCCCCCCCCCCCC
53.3154558211
723MethylationPPPPPPFRGARGGRS
CCCCCCCCCCCCCCC
43.5754558179
726MethylationPPPFRGARGGRSGGG
CCCCCCCCCCCCCCC
51.4254558203
729MethylationFRGARGGRSGGGPPN
CCCCCCCCCCCCCCC
34.6554558219
738MethylationGGGPPNGRGGPGGGM
CCCCCCCCCCCCCCC
54.24-
764PhosphorylationPGGGMGNSSGHRPHE
CCCCCCCCCCCCCCC
31.7822210691
765PhosphorylationGGGMGNSSGHRPHEG
CCCCCCCCCCCCCCC
42.4922210691
779PhosphorylationGPGGGMGSGHRPHEG
CCCCCCCCCCCCCCC
23.6426552605
790PhosphorylationPHEGPGGSMGGGGGH
CCCCCCCCCCCCCCC
21.8526552605

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of PP1RA_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
398SPhosphorylation

23186163

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of PP1RA_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
WDR82_HUMANWDR82physical
20516061
PP1A_HUMANPPP1CAphysical
20516061
PP1B_HUMANPPP1CBphysical
20516061
PP1G_HUMANPPP1CCphysical
20516061
TOX4_HUMANTOX4physical
20516061
PP1RA_HUMANPPP1R10physical
20516061
HSP74_HUMANHSPA4physical
20516061
PP1A_HUMANPPP1CAphysical
12574161

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of PP1RA_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-207 AND LYS-239, AND MASSSPECTROMETRY.
Phosphorylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-545, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-313 AND SER-591, ANDMASS SPECTROMETRY.
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-313, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-313, AND MASSSPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-256, AND MASSSPECTROMETRY.

TOP